TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in Cognitive Neurodevelopmental Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Motor Neurodevelopmental Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With New Heart Failure Hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity and specificity of mPDia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Framingham Risk Score for cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived helpfulness to reduce current stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients prescribed an antibiotic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SUS score assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vital signs measurement (Heart rate/ Respiratory rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly prevalence of LBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Weekly prevalence of SLBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of LBP at follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PENN shoulder score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seated basketball throw
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thumb up back (TUB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant pain levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of Total Urine SFN (Sulforaphane) Metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Total Plasma SFN (Sulforaphane) Metabolites Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Ki67 Positive Cells up to 8 Weeks Post-randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: patient's function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cervical Spine Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with choice of catheterization method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Histological Responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Aldara Cream 5% for alopecia areata
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of complications related to Implantable Venous Access Device
Endpoint domain: Adverse events/effects
Primary endpoint: Histological cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Chronic Neuropathic Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of episodes of nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Number of episodes of vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Ability to detect critical drops in SpHb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dependence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Physical Composite Summary
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Success Rate of Repair of Scleral Defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feasibility of detection and localization of radiotracer uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With a Dose Limited Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: side effects of enema types
Endpoint domain: Adverse events/effects
Primary endpoint: Agreement between algorithm and PSG reference standard for detection of OSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of intoxicated patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Hamilton Depression Rating Scale (HAM-D) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: immune recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ratio of patients free of seizure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Freedom from Major Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Time To Hemostasis (TTH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median headache score 0 hours after sumatriptan/placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median headache score 2 hours after sumatriptan/placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of multiorgan failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative CSF leaks
Endpoint domain: Adverse events/effects
Primary endpoint: Body mass index (BMI) at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerance of larazotide acetate
Endpoint domain: Adverse events/effects
Primary endpoint: Intestinal permeability ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Zonulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of combining Radium-223 with tasquinimod
Endpoint domain: Adverse events/effects
Primary endpoint: Pregnancy Loss or NICU Admission for Greater Than 48 Hours
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with AF admitted with acute cerebrovascular stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Generalized Anxiety Disorder-7 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Atypical Urinary Bile Acid Excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Natural Killer (NK) cell phenotype alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Brain Imaging: MRI & MRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NAA Levels in Urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time of Maximum Plasma Concentration (Tmax) of Misoprostol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Misoprostol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration time curve (AUC) of ipatasertib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) reached of ipatasertib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to maximum concentration (Tmax) of ipatasertib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death to discharge or at six months corrected gestational age
Endpoint domain: Mortality/survival
Primary endpoint: Major amputation
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with FDG-PET findings that contraindicate surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: change of the Neural respiratory drive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Penile erection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 75 Meter Self Selected Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Functional Performance (Continuous Scale; 10-items)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: acute oxygenation (pulse oximetry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: spirometry (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety of [124I] PSCA-Minibody
Endpoint domain: Adverse events/effects
Primary endpoint: Number of injection sessions to reach complete resolution of seroma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of platelets concentrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Bone Density Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiolucency Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiological recurrence rate of hiatal hernia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of non-emergence of bloody stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Workability
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Nocturnal oxygen desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severe Hypoglycemia Rescue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Change From Baseline in Weekly Number of UI Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Glycosylated Hemoglobin A1C (A1C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of postoperative residual curarisation
Endpoint domain: Adverse events/effects
Primary endpoint: K max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Durability without side effects of surgical device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Knowledge level of BLS
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: cT1 (inflammation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Forced Vital Capacity (FVC) percent predicted values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Forced Expiratory Volume in 1st second (FEV1) percent predicted values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Forced Expiratory Flow at 25% (FEF25%) percent predicted values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in 6-minutes walk distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New ischaemic brain lesion after CAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Patient Global Assessment of Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Stable Disease (SD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful extubation from mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Variation in DAS28 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients presenting a sleep onset
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Fugl-Meyer assessment for upper extremity (FMA-UE) for hand function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Ashworth scale for level of spasticity of affected arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Area under the ROC curve of biomarkers for the diagnosis of PE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PE related death
Endpoint domain: Mortality/survival
Primary endpoint: Sensory intensity ratings of dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Post Concussion Symptom Inventory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Morphological change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient completion of assessments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of people in open employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Decitabine plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in plasma choline concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in plasma betaine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in plasma dimethylglycine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: initial bone density scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of progression of bronchial dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: amount of unsolved medication-related problems
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Clinical Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing duration of the diabetic foot ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity Limitation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional Disorder
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percent of Participants With Visible Region of Interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of effective placements of balloon to occlude trachea via fetoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percent of Subjects With Worst-Itch Numeric Rating Scale 4-point Responder at Week 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfusion of Fresh Frozen Plasma (FFP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAP occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Respiration rate detection accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With One or More Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Abnormal Laboratory Values
Endpoint domain: Adverse events/effects
Primary endpoint: Development of deep vein thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of herpetic disease (viral shedding of HSV-1 and 2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: measurement of anterior-posterior diameters of aortic endoprosthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: detection of endoleaks after PCUS injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measurement of anterior-posterior diameters of endoleaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale for Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Units of Analgesics Used for Testicular Pain
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in Plasma Uric Acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self image and communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HIV RNA-1 Viral Load Less Than 400 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substantial equivalence of vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Eyes That Failed Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Running Related Lower Limb Injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Magnitude of hyperemia after PORH test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants remaining on perampanel monotherapy
Endpoint domain: Mortality/survival
Primary endpoint: pain during coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment follow-up compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: User-Friendliness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Simulator Sickness
Endpoint domain: Adverse events/effects
Primary endpoint: Driving Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ctDNA mutation profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Hemoglobin at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevention of bronchoconstriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to Peak (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of Propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of Remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reducing Pain During Device Injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lagophthalmos distance without pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphine equivalents used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ICIQ-SF
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neurogenic Bladder Symptom Score Questionnaire (NBSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualiveen
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Short Form Qualiveen (SF-Qualiveen)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The King's Health Questionnaire (KHQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Imaging biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported sexual activity
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Self-reported smoking status
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Subsequent incidents of intimate partner or sexual violence
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Malignancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: myocardial dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants Reporting Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severe TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Outcome of Death
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients attending screening test
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fracture displacement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fracture healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients with adverse events related to epidural anesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Pancreatic perfusion measured by computerized tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Left Ventricular Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Compromise of cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of change of Weight-bearing pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retraction Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Ocular and Systemic Adverse Events
Endpoint domain: Adverse events/effects